LitCovid-sentences  

PubMed:33123081 JSONTXT 19 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1 0-64 Sentence denotes Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient.
T2 65-75 Sentence denotes Objective:
T3 76-281 Sentence denotes We report the case of a young woman with postinfectious onset of myasthenia gravis after COVID-19 with mild respiratory symptoms and anosmia/ageusia 1 month before admission to our neurological department.
T4 282-290 Sentence denotes Methods:
T5 291-374 Sentence denotes Patient data were derived from medical records of Hannover Medical School, Germany.
T6 375-430 Sentence denotes Written informed consent was obtained from the patient.
T7 431-439 Sentence denotes Results:
T8 440-589 Sentence denotes The 21-year-old female patient presented with subacute, vertically shifted double vision evoked by right sided partial oculomotor paresis and ptosis.
T9 590-729 Sentence denotes About 4 weeks earlier she had suffered from mild respiratory symptoms, aching limbs and head without fever, accompanied by anosmia/ageusia.
T10 730-870 Sentence denotes During the persistence of the latter symptoms for around 10 days the patient had already noticed "tired eyes" and fluctuating double vision.
T11 871-1059 Sentence denotes Clinical assessment including a positive test with edrophonium chloride and increased acetylcholine receptor antibodies related the ocular manifestation etiologically to myasthenia gravis.
T12 1060-1276 Sentence denotes Antibodies (IgA/IgG) against SARS-CoV-2 using three different serological tests (Abbott, DiaSorin, Euroimmun) were detected in serum suggesting this specific coronavirus as previously infectious agent in our patient.
T13 1277-1383 Sentence denotes The myasthenic syndrome was treated successfully with intravenous immunoglobulins and oral pyridostigmine.
T14 1384-1395 Sentence denotes Conclusion:
T15 1396-1519 Sentence denotes This is the first case presentation of postinfectious myasthenia gravis as neurological complication in a COVID-19 patient.